Other
Peptest™
Peptest™ is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Prevalence of Pharyngolaryngeal Reflux in Patients Treated for Obstructive Sleep Apnea Syndrome
NCT05110352
completednot_applicable
Validation of Peptest™ for the Detection of Reflux in Cough
NCT03851393
completednot_applicable
Three Methods Used in the Diagnosis of EER in Children With OME
NCT02183961
completednot_applicable
Suitable Method for Routine Diagnostics of EER in Children With Otitis Media With Effusion
NCT02183974
Clinical Trials (4)
Showing 4 of 4 trials
NCT05110352Not Applicable
Prevalence of Pharyngolaryngeal Reflux in Patients Treated for Obstructive Sleep Apnea Syndrome
NCT03851393Not Applicable
Validation of Peptest™ for the Detection of Reflux in Cough
NCT02183961Not Applicable
Three Methods Used in the Diagnosis of EER in Children With OME
NCT02183974Not Applicable
Suitable Method for Routine Diagnostics of EER in Children With Otitis Media With Effusion
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4